Roland Baron

Corporate Officer/Principal presso Harvard Medical School

Health Technology

Consumer Services

Commercial Services

Profilo

Roland Baron is the founder of ProSkelia SAS, which was founded in 2002.
He is currently the Chairman-Oral Medicine at Harvard School of Dental Medicine and a Professor at Harvard Medical School.
Dr. Baron was previously an Independent Non-Executive Director at Bone Therapeutics SA from 2015 to 2019.
He was also a Vice President at Aventis SA and Hoechst Marion Roussel, Inc. Additionally, he was the President & Chief Scientific Officer at Kyowa Kirin International Plc and ProStrakan, Inc. Dr. Baron was the President of The American Society for Bone & Mineral Research and a Professor at Yale School of Medicine from 1977 to 2007.
He received his doctorate degree from Université de Paris 5 René Descartes.

Posizioni attive di Roland Baron

Società	Posizione	Inizio
Harvard Medical School	Corporate Officer/Principal	01/01/2008
Harvard School of Dental Medicine	Corporate Officer/Principal	01/01/2008

Tutte le posizioni attive di Roland Baron

Precedenti posizioni note di Roland Baron

Società	Posizione	Fine
BIOSENIC SA	Direttore/Membro del Consiglio	12/06/2019
Yale School of Medicine	Corporate Officer/Principal	01/01/2007
ProSkelia SAS ProSkelia SAS Miscellaneous Commercial ServicesCommercial Services Part of Galapagos NV, ProSkelia SAS conducts bone disease research. The company is based in Romainville, France. The French company was founded by Roland Baron. ProSkelia was acquired by Galapagos Genomics NV from Kyowa Kirin International Plc on December 22, 2006 for $59.24 million.	Fondatore	-
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.	Presidente	02/04/2006
Hoechst Marion Roussel, Inc.	Corporate Officer/Principal	01/01/2002

Vedi nel dettaglio l'esperienza di Roland Baron

Formazione di Roland Baron

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Roland Baron

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	8
Bone Therapeutics SA Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium.	Health Technology
Hoechst Marion Roussel, Inc.
Aventis SA Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France.	Health Technology
ProSkelia SAS ProSkelia SAS Miscellaneous Commercial ServicesCommercial Services Part of Galapagos NV, ProSkelia SAS conducts bone disease research. The company is based in Romainville, France. The French company was founded by Roland Baron. ProSkelia was acquired by Galapagos Genomics NV from Kyowa Kirin International Plc on December 22, 2006 for $59.24 million.	Commercial Services
Université de Paris 5 René Descartes	Consumer Services
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.	Health Technology
ProStrakan, Inc. ProStrakan, Inc. Pharmaceuticals: MajorHealth Technology Part of Kirin Holdings Co., Ltd., ProStrakan, Inc. develops, manufactures, and distributes prescription medicines. The company is based in Bridgewater, NJ.	Health Technology
The American Society for Bone & Mineral Research The American Society for Bone & Mineral Research Miscellaneous Commercial ServicesCommercial Services The American Society for Bone & Mineral Research engages in bone, mineral and musculoskeletal research. The non-profit company is based in Washington.	Commercial Services